ASCO’s mission is to conquer cancer through research, education, and promotion of the highest quality patient care. We work toward this goal in part through the dissemination of high-quality, ...

All content dealing with understanding the provision of care—the mechanics of practice, care delivery, quality improvement, value, and equity—is the purview of JCO OP. JCO OP also addresses an ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent Treatment Because of a lack of evidence-based ...

JCO Journals employ a single-blind review process. Reviewers know the identity of the authors, but authors do not know the identity of the reviewers. Approximately 1/3 of submissions are rejected ...

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3 ...

The 2024 ASCO Annual Meeting Proceedings – Head and Neck Cancer Abstracts Edition is a listing of all accepted abstracts from the head and neck cancer track of the 2024 ASCO Annual Meeting.

Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus A systematic review of randomized controlled trials of MM that reported testing ...

Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma A total of 121 patients (previous ICI-treated cohort, n = 31, and each of ...

To wrap up 2024, we proudly present the Top 5 articles from each JCO Journal. The editors and staff are grateful to all of our authors for choosing JCO Journals to publish their work. Meric-Bernstam ...

Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...